Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
about
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesUse of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart LesionsMechanical valve obstruction: Review of diagnostic and treatment strategiesNon-infective endocarditis with systemic embolization and recurrent stroke in systemic sclerosisNew insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolismSingle vs Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation: A Systematic ReviewSupplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysisUrgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studiesMultiple systemic embolism in infective endocarditis underlying in Barlow's disease.Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.Prolonged use of fondaparinux for perioperative bridging: a case report of a patient with mechanical heart valve and heparin-induced thrombocytopenia.Anticoagulation for the acute management of ischemic strokeEarly Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center ExperienceAntithrombotic strategy in the three first months following bioprosthetic heart valve implantation.Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questionsPregnancy complicated by valvular heart disease: an update.Right atrial mass in a 23-year-old woman with molar pregnancy.Effect of a combined anti-thrombotic therapy of thrombosis on prosthetic heart valves.Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Patient Management with Metallic Valve Prosthesis during Pregnancy and Postpartum Period.Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and Tricuspid Valves: The Largest Survival Analysis to Date.Stroke prevention: managing modifiable risk factors.Transitions of care in anticoagulated patients.Assessment of psychometric properties of the Brazilian version of the oral anticoagulation knowledge test.Nonbacterial thrombotic endocarditis: A rare manifestation of gynecologic cancerDiagnosis of an aortic valvular lesion. Non-bacterial thrombotic endocarditis (NBTE).Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Documentation of various approaches and outcomes in patients on warfarin undergoing dental procedures: a review article.Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair.Seventeen-millimeter St. Jude Medical Regent valve in patients with small aortic annulus: dose moderate prosthesis-patient mismatch matter?The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation.Inappropriate combination of warfarin and aspirinDabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: protocol.Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.A review of antithrombotic therapy for transcatheter aortic valve replacement.
P2860
Q24632927-2097D38F-EEC0-4CA3-996C-914F7294F9FFQ24632951-AB1037F2-3818-4B61-A7B6-D6D56BCB49DCQ24632982-74260710-6DB6-4B19-9D90-56E58D8F8ADFQ26764853-48CEBF47-02AC-4E7D-A406-E8ED19AD334DQ26771120-5A17B7FF-5521-4B9A-9618-1EA1E5D01D4EQ26778627-63E08305-D6E4-45CB-995C-4B6FE8A28816Q26786574-D359C6CE-B782-46BA-B118-6FAB971407ECQ26799407-44B920E0-62F8-4854-B81B-7FAF8D6656D2Q26852661-9324C85E-16EC-4EF1-B76D-AB61006A3109Q27014924-75483948-9B42-478A-B0ED-CD780F8E7F52Q27312170-534BE1A6-DCC3-4CC0-A849-F9419FBC036CQ33414039-DEA84F95-45D5-40E6-9162-E9673866CA46Q33427583-604D71CF-1F57-453D-89FD-B167B3462AE7Q33653096-B4C37673-8FE2-4EA1-B27A-50690115FED4Q33832680-693DF3EC-573B-4F42-9FEF-063945BBCD77Q33843461-889FE92C-EFA1-457B-94ED-5FB85C626A30Q34666269-CE39064B-88E7-4165-9B31-1235058579D1Q35021794-6B6FF168-B276-46E8-8758-01CE93368401Q35180789-B181E793-FD80-4FD3-9BE3-AF03F96C7424Q35290356-69D8666D-3281-4098-9849-69B26F98AB03Q35752573-E376DEE4-A155-4539-B2AC-07F1D87AA01CQ35752603-931C9B6E-A2BF-414A-A50C-88EE1B95F9AAQ35752608-17BCBD0C-624B-4724-BCE4-F9219EF0945DQ36248184-B376C64E-7599-4A56-B0C8-6B706490D428Q36334466-8027BEDD-A866-47C8-A02E-450D610FB41CQ36418118-06E6D360-5607-41E7-93D5-4DFFB83BB68BQ36957947-890EB088-A062-47D4-821A-B6FB170A63F4Q37038025-32C5FE0B-2D97-41AC-BC4D-9476C66C2F22Q37086868-AB906702-DC9B-4023-B84D-2751ECA2F66BQ37123888-A12DF6B4-D3D7-4097-BB06-1F2467381407Q37185839-5FCE4309-FC7B-4F7E-9A76-F399F78EFC4BQ37251490-8477BBAB-81B6-413F-BE51-98D70FBB0A54Q37271032-51DB42B3-A28B-48BC-9EA7-D539B5F45217Q37427563-441824FC-453C-4F1B-BC36-9A5EF3D4020BQ37497343-18A493F2-CF11-4F72-AF42-F83664F6ECD2Q37594817-02F58865-E974-44F9-900E-FBF33A520DD5Q37680357-E790DE11-1E18-4169-B4A3-8787548785DAQ37731381-1ABB3BC6-291B-40F2-BA0C-1E841AE7F4A0Q38076751-828D4E61-E79F-43CB-9633-34A77D3846BAQ38079918-6660F00B-78B4-4E03-9476-01C68B014C5C
P2860
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@ast
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@en
type
label
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@ast
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@en
prefLabel
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@ast
Antithrombotic and thrombolyti ...... Clinical Practice Guidelines.
@en
P2093
P2860
P356
P1433
P1476
Antithrombotic and thrombolyti ...... d Clinical Practice Guidelines
@en
P2093
Fraser D Rubens
Jack C Sun
Kevin H Teoh
Richard P Whitlock
P2860
P304
e576S-e600S
P356
10.1378/CHEST.11-2305
P407
P433
P577
2012-02-01T00:00:00Z